The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Mylan's revenues will grow 3.0% and EPS will grow 13.3%.
The average estimate for revenue is $1.74 billion. On the bottom line, the average EPS estimate is $0.68.
Last quarter, Mylan booked revenue of $1.63 billion. GAAP reported sales were 3.0% higher than the prior-year quarter's $1.58 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.62. GAAP EPS of $0.27 for Q1 were 10.0% lower than the prior-year quarter's $0.30 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 43.2%, 70 basis points better than the prior-year quarter. Operating margin was 17.9%, 20 basis points better than the prior-year quarter. Net margin was 6.6%, 160 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $7.09 billion. The average EPS estimate is $2.87.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 543 members out of 578 rating the stock outperform, and 35 members rating it underperform. Among 182 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 176 give Mylan a green thumbs-up, and six give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Mylan is outperform, with an average price target of $31.92.
- Add Mylan to My Watchlist.